NeoGenomics
256 hedge funds and large institutions have $1.54B invested in NeoGenomics in 2025 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 72 increasing their positions, 91 reducing their positions, and 32 closing their positions.
350% more call options, than puts
Call options by funds: $12.6M | Put options by funds: $2.8M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more capital invested
Capital invested by funds: $995M → $1.54B (+$545M)
34% more first-time investments, than exits
New positions opened: 43 | Existing positions closed: 32
1.3% more ownership
Funds ownership: 99.77% → 101.07% (+1.3%)
1% more funds holding
Funds holding: 254 → 256 (+2)
21% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 91
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
+$30.9M |
| 2 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$26.7M |
| 3 |
D.E. Shaw & Co
New York
|
+$21.6M |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
+$17.6M |
| 5 |
SC
Samlyn Capital
New York
|
+$15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$34.3M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$19.6M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$15.1M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14.9M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$11.6M |
NEO Hedge Fund Activity: Q4 2025 in Review
256 of the 8,265 institutional investors tracked by Wall St. Rank reported a position in NeoGenomics (NEO) for Q4 2025, worth a combined $1.54B — up 55% from $995M a quarter earlier.
Buyers outnumbered sellers: 43 funds opened new NEO positions and 32 closed out — a net gain of 11 holders — while 72 added to existing stakes and 91 trimmed.
The largest buyer was Braidwell, adding an estimated $30.9M. The largest seller was Deerfield Management, exiting entirely with an estimated $34.3M sold.
- 256 institutional investors held NeoGenomics (NEO) as of Q4 2025, up from 254 in Q3 2025.
- Funds reported $1.54B of NeoGenomics stock for Q4 2025, up 55% quarter-over-quarter.
- 43 funds opened new NeoGenomics positions in Q4 2025 and 32 closed out, a net change of +11 holders.
- The largest NeoGenomics buyer in Q4 2025 was Braidwell, an estimated $30.9M added.
- The largest NeoGenomics seller in Q4 2025 was Deerfield Management, an estimated $34.3M sold.
Based on aggregated 13F filings for Q4 2025.